Status:
NOT_YET_RECRUITING
Prognostic Value of the CALLY Index in Patients Undergoing Primary PCI
Lead Sponsor:
Assiut University
Conditions:
Primary Percutaneous Coronary Intervention
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate the relationship between the admission CALLY index and short-term adverse outcomes in STEMI patients undergoing PPCI. Specifically, it seeks to determine whether the CALLY ...
Detailed Description
* ST-elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality worldwide. Early risk stratification in patients undergoing primary percutaneous coronary intervention (...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Diagnosis of STEMI based on 4th universal definition of myocardial infarction
- Undergoing Primary PCI within guideline-recommended timeframes
- Provided informed consent to participate in the study
Exclusion
- Active infection (as detected by baseline leukocytosis on admission), autoimmune or inflammatory disease affecting CRP, albumin, or lymphocyte counts
- Chronic liver disease or advanced malignancy
- Patients receiving immunosuppressive therapy
- Refusal to participate
Key Trial Info
Start Date :
September 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 25 2026
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT07203573
Start Date
September 25 2025
End Date
October 25 2026
Last Update
October 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.